Lightrock Netherlands B.V. Acquires Shares of 279,283 Healthpeak Properties, Inc. (NYSE:DOC)

Lightrock Netherlands B.V. acquired a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 279,283 shares of the real estate investment trust's stock, valued at approximately $5,689,000. Healthpeak Properties makes up approximately 2.0% of Lightrock Netherlands B.V.'s portfolio, making the stock its 25th largest holding.

Several other large investors also recently bought and sold shares of DOC. AMF Tjanstepension AB purchased a new stake in Healthpeak Properties during the 3rd quarter valued at about $15,548,000. Mather Group LLC. purchased a new stake in Healthpeak Properties during the 3rd quarter valued at about $60,000. CWM LLC purchased a new stake in Healthpeak Properties during the 3rd quarter valued at about $1,298,000. UMB Bank n.a. purchased a new stake in Healthpeak Properties during the 3rd quarter valued at about $40,000. Finally, Livforsakringsbolaget Skandia Omsesidigt purchased a new stake in Healthpeak Properties during the 3rd quarter valued at about $67,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DOC. Wells Fargo & Company dropped their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Tuesday, December 10th. Wedbush dropped their price target on shares of Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a research note on Friday. Royal Bank of Canada increased their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a research note on Monday, November 4th. Robert W. Baird dropped their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Tuesday. Finally, Morgan Stanley raised shares of Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target for the company in a research note on Wednesday, January 15th. One research analyst has rated the stock with a sell rating, three have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $24.00.

Healthpeak Properties Trading Down 1.9 %

Shares of DOC stock traded down $0.39 during trading hours on Friday, hitting $19.57. The company had a trading volume of 4,495,661 shares, compared to its average volume of 4,839,062. The company's fifty day moving average is $20.36 and its 200 day moving average is $21.46. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.31. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26. The stock has a market capitalization of $13.69 billion, a PE ratio of 55.92, a price-to-earnings-growth ratio of 2.18 and a beta of 1.15.

Healthpeak Properties Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th will be issued a dividend of $0.305 per share. The ex-dividend date of this dividend is Friday, February 14th. This is a positive change from Healthpeak Properties's previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a yield of 6.23%. Healthpeak Properties's dividend payout ratio is 348.57%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.